A-012 Predictive Value of Baseline Alpha Defensin Level in Patients with Stable Coronary Artery Disease: A Retrospective Single Center Study
Abstract Background Inflammation plays a central role in atherogenesis. The major neutrophilic peptide alpha-defensin is a promising evolving risk factor for atherosclerosis. The aim of the present study was to examine the role of alpha-defensin in predicting future major adverse cardiovascular even...
Saved in:
Published in | Clinical chemistry (Baltimore, Md.) Vol. 70; no. Supplement_1 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
02.10.2024
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background Inflammation plays a central role in atherogenesis. The major neutrophilic peptide alpha-defensin is a promising evolving risk factor for atherosclerosis. The aim of the present study was to examine the role of alpha-defensin in predicting future major adverse cardiovascular events (MACE) occurrence in fully revascularized patients with stable coronary artery disease (CAD) under optimal medical therapy. Methods We retrospectively examined the prognostic value of baseline plasma alpha-defensin levels in predicting MACE occurrence in 174 fully revascularized patients for stable CAD. Demographic, clinical, angiographic, and laboratory data were collected from patients' electronic medical records (EMR). Alpha-defensin levels were measured in samples of EDTA plasma using ELISA kit (HyCult Biotechnology). Other Biochemical parameters were analyzed in serum using COBAS-8000 systems (Roche). Results Alpha-defensin levels were 20% higher among demised patients (10,859 pg/ml, IQR [6,920 to 23,320] vs. 9,020 pg/ml, IQR [5,540 to 16,180] pg/ml, P = 0.15). The absolute increase in mortality risk in patients with alpha-defensin levels greater than the median values was 72.5% (P = 0.33). Log-rank analysis proved both recurrent PCI for de novo lesions (14.9% and 2.3%) and the composite of mortality and recurrent PCI for de novo lesions (27.6% vs. 9.2%) were significantly related to alpha-defensin values greater than the median (>9200 pg/ml). Conclusions Baseline plasma alpha-defensin is an independent predictor of mortality and recurrent PCI among patients with stable CAD. Alpha-defensin may evolve as a promising factor in cardiovascular risk assessment beyond traditional risk factors. Targeting alpha-defensin to ameliorate MACE occurrence should be addressed in future studies. |
---|---|
AbstractList | Abstract Background Inflammation plays a central role in atherogenesis. The major neutrophilic peptide alpha-defensin is a promising evolving risk factor for atherosclerosis. The aim of the present study was to examine the role of alpha-defensin in predicting future major adverse cardiovascular events (MACE) occurrence in fully revascularized patients with stable coronary artery disease (CAD) under optimal medical therapy. Methods We retrospectively examined the prognostic value of baseline plasma alpha-defensin levels in predicting MACE occurrence in 174 fully revascularized patients for stable CAD. Demographic, clinical, angiographic, and laboratory data were collected from patients' electronic medical records (EMR). Alpha-defensin levels were measured in samples of EDTA plasma using ELISA kit (HyCult Biotechnology). Other Biochemical parameters were analyzed in serum using COBAS-8000 systems (Roche). Results Alpha-defensin levels were 20% higher among demised patients (10,859 pg/ml, IQR [6,920 to 23,320] vs. 9,020 pg/ml, IQR [5,540 to 16,180] pg/ml, P = 0.15). The absolute increase in mortality risk in patients with alpha-defensin levels greater than the median values was 72.5% (P = 0.33). Log-rank analysis proved both recurrent PCI for de novo lesions (14.9% and 2.3%) and the composite of mortality and recurrent PCI for de novo lesions (27.6% vs. 9.2%) were significantly related to alpha-defensin values greater than the median (>9200 pg/ml). Conclusions Baseline plasma alpha-defensin is an independent predictor of mortality and recurrent PCI among patients with stable CAD. Alpha-defensin may evolve as a promising factor in cardiovascular risk assessment beyond traditional risk factors. Targeting alpha-defensin to ameliorate MACE occurrence should be addressed in future studies. |
Author | Amsalem, N Roguin, A Shapira, M Abu Fanne, R Egbaria, D Kobo, O |
Author_xml | – sequence: 1 givenname: M surname: Shapira fullname: Shapira, M – sequence: 2 givenname: A surname: Roguin fullname: Roguin, A – sequence: 3 givenname: O surname: Kobo fullname: Kobo, O – sequence: 4 givenname: D surname: Egbaria fullname: Egbaria, D – sequence: 5 givenname: N surname: Amsalem fullname: Amsalem, N – sequence: 6 givenname: R surname: Abu Fanne fullname: Abu Fanne, R |
BookMark | eNo1kE1uwjAQha2KSgXaG3ThCwTsxLGT7lLon4RUVFC3keOMG1fBQXZIxR166BpBV29GevPm6Zugke0sIHRPyYySPJmr1ljVwG7eDBIo4TNC4ys0pmlCoizldITGhJA8yikTN2ji_XdYmcj4GP0WUTDjtYPaqN4MgD9lewDcafwoPYRgwEW7byReggbrjcUrGKDFYVjL3oDtPf4xfYM3vaxawIvOdVa6Iy5cD0GWxkMIesAF_oDedX4P5z8bY79O_pAALlwf6uMtutay9XB30SnaPj9tF6_R6v3lbVGsIpWlcRTruE40S6XiXCSMCCZoAnmlVZULyjNdk6omUgsFKaVQy5hJDmlN05xlXPBkitg5VoU63oEu987sQueSkvIEtPwHWl6AloFR8gfcdnAC |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1093/clinchem/hvae106.012 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1530-8561 |
ExternalDocumentID | 10_1093_clinchem_hvae106_012 |
GroupedDBID | --- -~X .55 04C 0R~ 18M 29B 4.4 53G 5GY 5RE 5WD 6J9 7RV AABZA AACZT AAPQZ AAPXW AAQQT AARHZ AASNB AAUAY AAVAP AAYXX ABCQX ABJNI ABMNT ABNHQ ABOCM ABPPZ ABPQP ABPTD ABQNK ABSQV ABWST ABXVV ACGOD ACIHN ACIWK ACPRK ACYHN ADBBV ADGZP ADIPN ADQBN ADVEK AEAQA AELWJ AENEX AETBJ AFFZL AFGWE AFRAH AGINJ AGQXC AGUTN AHMBA AJEEA ALIPV ALMA_UNASSIGNED_HOLDINGS ATGXG BAWUL BCRHZ BENPR BEYMZ BHPHI BTFSW C45 CITATION CS3 DIK DU5 E3Z EBS ENERS F5P F9R FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT H13 HCIFZ H~9 IAO IEA IGS IH2 IHR IHW INIJC KOP KQ8 KSI KSN L7B NOMLY OAUYM OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF PV9 RHF RHI RNS ROX RUSNO RZL SJN TCC TEORI TR2 TWZ U5U UCJ UNMZH WH7 WOQ X7M YBU YHG YWH YXANX |
ID | FETCH-LOGICAL-c852-2f2d3f45ac66734074713e9bfcb97168fd0bd0af7ce511eda24a6e5d159486763 |
ISSN | 0009-9147 |
IngestDate | Wed Oct 09 16:49:08 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c852-2f2d3f45ac66734074713e9bfcb97168fd0bd0af7ce511eda24a6e5d159486763 |
ParticipantIDs | crossref_primary_10_1093_clinchem_hvae106_012 |
PublicationCentury | 2000 |
PublicationDate | 2024-10-02 |
PublicationDateYYYYMMDD | 2024-10-02 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-02 day: 02 |
PublicationDecade | 2020 |
PublicationTitle | Clinical chemistry (Baltimore, Md.) |
PublicationYear | 2024 |
SSID | ssj0004786 |
Score | 2.5047112 |
Snippet | Abstract Background Inflammation plays a central role in atherogenesis. The major neutrophilic peptide alpha-defensin is a promising evolving risk factor for... |
SourceID | crossref |
SourceType | Aggregation Database |
Title | A-012 Predictive Value of Baseline Alpha Defensin Level in Patients with Stable Coronary Artery Disease: A Retrospective Single Center Study |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3batwwEBVLCn0rvdI789C3xRtbtnftvjlLS2i7vSTbkjcjWVISCOuyeAvtN_R3-n-d0cWxSyhNX4wwa7H2HEaj0ZkzjL1I57jpkomJlEnyKFNlGhW4EYpSrnKpRFE2Vqx69X5--Dl7c5KfTCa_BqylXSdnzY8r60r-x6p4D-1KVbLXsGw_Kd7AMdoXr2hhvP6TjSvcotsuTOrcuq3pF3Gxs0mAA2ELzfW0olpa9CqGiOqb6TviCFGO46PTU_XFbRhyUgXVkuQMiEZXEdHzO0lz0umNq14_0t22DYWZ02Nc8ugJkvTcWjbi6Hx4GQoum9BQjkLZA3HRnQdm70rNBmmI4zNBR_6j_OxRe7rzEgf9utBKm9v90O8ETiXu9sUld9lnMHhmuXB85JVLdLpOeXOmgyOOoyJ3Qu3BU7sWIx6RtuupTaHWyZVrgdPJogJTelUcnn0TOqHDJ0_cHolv_7Eo9lRFd0if1mGe2s9Sx9Tb-gZflDkxSd9-GojUL2yD0f61QsVmme6HWfYH_2UQEQ1Cm_VtdsvvSaByALvDJnpzl91cedbFPfbT4gwucQYWZ9AaCDgDizMIOAOLM8BBwBkQzsDhDALOwOEMPM5eQgUjlIFDGTiUgUXZfbZ-_Wq9PIx8F4-oKXIeccNVarJcNNRgNqN-DUmqS2kaSeplhVGxVLEwi0Zj7K-V4JmY61wlpCM0x9XvAdvbtBv9kEGSCcFlWuiiSDIuND6bNPgwL5O0yWLziEXhQ9ZfnVZL_TfzPb7m759QUid2DFD-lO11251-hiFpJ59bAPwG4eSPwQ |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A-012+Predictive+Value+of+Baseline+Alpha+Defensin+Level+in+Patients+with+Stable+Coronary+Artery+Disease%3A+A+Retrospective+Single+Center+Study&rft.jtitle=Clinical+chemistry+%28Baltimore%2C+Md.%29&rft.au=Shapira%2C+M&rft.au=Roguin%2C+A&rft.au=Kobo%2C+O&rft.au=Egbaria%2C+D&rft.date=2024-10-02&rft.issn=0009-9147&rft.eissn=1530-8561&rft.volume=70&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Fclinchem%2Fhvae106.012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_clinchem_hvae106_012 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9147&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9147&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9147&client=summon |